Does Medicaid Cover Sublocade in Michigan? What You Need to Know About Coverage
About 20.6 percent of Medicaid beneficiaries age 12 and older have a substance use disorder. This affects millions of the more than 87 million Americans enrolled in Medicaid as of April 2023. Opioid addiction remains a critical health challenge. You need to know your treatment options and coverage. Sublocade, a monthly extended-release buprenorphine injection, offers a treatment that works. Your doctor administers it instead of you picking up daily medication.
Does Medicaid cover Sublocade in Michigan? You can access the care you need if you know how Medicaid coverage works in Michigan for this treatment. This piece explains Michigan Medicaid’s coverage policies for Sublocade. You’ll learn about requirements, where you can receive treatment, and what you need to qualify.
Does Medicaid Cover Sublocade in Michigan
Michigan Medicaid does cover Sublocade to treat opioid use disorder. Your coverage pathway depends on whether you receive services through Fee-For-Service plans or Managed Care Plans, with specific billing procedures for each.
Coverage Under Fee-For-Service Plans
Fee-For-Service plans in Michigan provide Sublocade coverage through two distinct billing methods. You can access Sublocade as a pharmacy benefit. Your provider purchases the medication through a specialty pharmacy and bills Magellan Medicaid Administration for reimbursement. Your practitioner can also use the buy-and-bill process as a medical benefit. They purchase Sublocade and submit prior authorization requests to the Michigan Department of Health and Human Services Program Review Division.
The MDHHS fee-for-service program carves out selected drugs from managed care plan coverage and pays pharmacies. Pharmacies bill Magellan Medicaid Administration for reimbursement of these carved-out medications. Sublocade requires prior authorization for coverage when billed as an unclassified injection under code J3490.
Coverage Under Managed Care Plans
Michigan contracts with capitated managed care plans that provide services for beneficiaries. These plans handle most pharmacy services. The Michigan Department of Health and Human Services created a Common Formulary to streamline drug coverage policies in all contracted Medicaid Health Plans for members and providers.
Many people overlook this point: October 1, 2020 marked when Policy Bulletin 20-51 required Medicaid Health Plans to follow the Michigan Preferred Drug List used by the Fee-for-Service pharmacy program, described as the Single PDL. This standardization means managed care plans must arrange their coverage with FFS requirements. They may be less restrictive than Common Formulary parameters for drug classes not on the Single PDL.
Sublocade as Preferred vs Non-Preferred Drug
Sublocade’s formulary status affects your out-of-pocket costs. Products listed on the Michigan Pharmaceutical Product List but not on the Common Formulary remain available through a non-formulary prior authorization process. Your health plan determines whether Sublocade qualifies as a preferred or non-preferred medication. This influences coverage restrictions and potential cost-sharing requirements.
Most patients with Medicaid pay low or no cost for Sublocade when it qualifies as a preferred drug treatment by their state health plan. Your specific costs vary based on formulary placement and whether your plan designates Sublocade as preferred status.
What is Sublocade and How Does It Work
Sublocade represents an extended-release buprenorphine formulation designed for patients diagnosed with moderate to severe opioid use disorder. The FDA approved this treatment on November 30, 2017, as the first monthly injectable buprenorphine option.
Monthly Extended-Release Buprenorphine Injection
Your healthcare provider administers Sublocade as a subcutaneous injection into your abdomen or back of the upper arm. The solution forms a gel-like depot under your skin after injection and releases buprenorphine into your bloodstream throughout the monthly dosing interval. This delivery mechanism employs the ATRIGEL Delivery System, which creates a solid deposit containing buprenorphine. The depot releases medication through diffusion and biodegradation, and therapeutic plasma concentrations remain stable for the full month.
The recommended dosing starts with 300 mg monthly for your first two months. A maintenance dose of 100 mg per month follows. Your provider may increase the maintenance dose to 300 mg monthly if you tolerate the 100 mg dose but don’t show satisfactory clinical response based on self-reported illicit opioid use or positive urine drug screens. Minimum spacing between consecutive doses requires 26 days.
How Sublocade Is Different from Daily Medications
Sublocade eliminates the need for daily medication adherence, unlike sublingual buprenorphine products that you take daily. Transmucosal formulations may not sustain therapeutic levels throughout the day and require daily compliance. Sublocade maintains steady medication levels all month with no daily fluctuations.
FDA-Approved Treatment for Opioid Use Disorder
Sublocade functions as a partial opioid agonist and binds to the same brain receptors as opioids without producing intense euphoria. 28% of patients receiving Sublocade with counseling achieved treatment success compared to 2% on placebo with counseling in clinical studies. You must stabilize on transmucosal buprenorphine for at least seven days before starting Sublocade.
Michigan Medicaid Requirements for Sublocade Coverage
Securing Medicaid coverage for Sublocade in Michigan requires meeting specific clinical and administrative criteria. Your eligibility begins with age, as you need to be 18 years or older to qualify for coverage.
Prior Authorization Process
Your provider submits prior authorization requests through Michigan’s standardized process. The Michigan Automated Prescription System (MAPS) or NarxCare report needs review within 30 days of your request. Requests submitted by Physician Assistants and Nurse Practitioners require additional documentation that includes the provider’s xDEA number, xDEA expiration date, and the collaborating physician’s information.
A toxicology screen from a commercial lab, less than 30 days old, needs to accompany your initial authorization request. This requirement will give appropriate monitoring of your treatment progress.
Substance Use Disorder Counseling Documentation
Your treatment needs to include participation in a complete program with counseling and psychosocial support. Treatment-naïve patients need counseling with a certified addiction counselor. Narcotics Anonymous, Alcoholics Anonymous, or other community-based 12-step programs alone do not satisfy this requirement when you initiate treatment.
Starting with Transmucosal Buprenorphine First
You need to stabilize on transmucosal buprenorphine containing product equivalent to 8 to 24 mg of buprenorphine daily for a minimum of 7 days before receiving your first Sublocade injection. This requirement applies unless you’re already being treated with buprenorphine.
Maximum Dose and Treatment Duration Limits
Your initial dose consists of 300 mg injections administered once every 28 days for two months. Maintenance treatment continues with 100 mg monthly after this. The quantity limit caps coverage at 300 mg per month. Injections need to maintain a minimum 26-day interval between doses. Initial authorizations grant 6 months of coverage, with reauthorization available for an additional 12 months when chart notes document positive response to therapy.
Where You Can Receive Sublocade in Michigan
Receiving Sublocade in Michigan involves visiting specific healthcare settings where certified providers administer the monthly injection. Your treatment location depends on provider availability and your healthcare priorities.
Narcotic Treatment Programs (NTPs)
Narcotic Treatment Programs provide structured environments to administer Sublocade. These SAMHSA-certified facilities provide medication-assisted treatment with counseling services required for Medicaid coverage in Michigan.
Physician Offices and Outpatient Clinics
Healthcare professionals administer Sublocade injections in outpatient settings, in the abdominal area typically. Physician offices like The Family Doc provide Medication-Assisted Treatment that combines Sublocade with expert counseling and medical supervision within primary care settings. These clinics provide detailed care where licensed professionals handle the subcutaneous injection procedure. Outpatient administration allows you to receive monthly treatment without hospitalization.
Hospital-Based Administration
Hospital settings provide another option to administer Sublocade, especially when integrated care coordination is beneficial. Only certified healthcare providers can administer this specialized medication.
Finding Participating Providers
Multiple resources help locate Sublocade providers in Michigan. The Sublocade website has a free provider locator tool that lists physicians, nurse practitioners and physician assistants who have prescribed Sublocade within the previous two years. Michigan has multiple sites where you can get Sublocade injections and comprehensive care including counseling. The SAMHSA buprenorphine practitioner locator also identifies qualified providers throughout Michigan.
Find Coverage Today
Michigan Medicaid covers Sublocade and gives you a monthly treatment option that works for opioid use disorder. You need to meet specific criteria to access this medication. These include prior authorization, transmucosal buprenorphine stabilization and counseling program participation. Understanding these requirements helps you work with your healthcare provider to secure the treatment you need. Use available locator tools to contact participating providers and begin your recovery with Sublocade.